Gardasil 9 syringe 0.5ML
Ended Awarded
- Contract number
- SPE2DB25FJG59
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $13,209
Award facts
- Contract value 100% obligated
- $13,209.05 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $13,209.05 delivery order to AmerisourceBergen Drug Corp for GARDASIL 9 vaccine syringes (0.5ML) on August 6, 2025, with completion scheduled for August 7, 2025. This competitively awarded, firm fixed-price contract contains no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which is valued at $999,999,999.00 and extends through December 2026. This prime IDC serves as a comprehensive global pharmaceutical support vehicle enabling AmerisourceBergen to supply pharmaceutical products and medical supplies to support military healthcare programs worldwide.
AmerisourceBergen Drug Corp is a major pharmaceutical distributor and critical vendor for federal medical procurement, particularly serving military and veteran healthcare systems through the Defense Health Agency and other government healthcare organizations. The company has established a substantial portfolio of federal contracts involving delivery orders for brand-name and generic medications, vaccines, medical devices, and specialized healthcare commodities across multiple therapeutic domains. The GARDASIL 9 delivery represents a routine replenishment order of human papillomavirus vaccine under the established DLA prime vendor relationship, supporting the Defense Health Agency's immunization requirements.
Quick answers
Who was awarded contract SPE2DB25FJG59?
SPE2DB25FJG59 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on August 6, 2025.
How much is contract SPE2DB25FJG59 worth?
The government has obligated $13,209 on SPE2DB25FJG59.
Is contract SPE2DB25FJG59 an order under another contract?
Yes. SPE2DB25FJG59 is a delivery order under SPE2DB22D2206, an indefinite delivery contract.
Was contract SPE2DB25FJG59 competed?
The extent of competition for SPE2DB25FJG59 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award